| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Veliparib |
➤ Sign Up |
1H-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors |
Abbott Laboratories Inc. (Abbott Park, IL) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 2 |
Abbott Laboratories (Abbott Park, IL) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
2-{(R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |
AbbVie Inc. (North Chicago, IL) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins |
The University of Chicago (Chicago, IL) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide crystalline form 1 |
AbbVie Inc. (North Chicago, IL) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
Metalloinsertor complexes targeted to DNA mismatches |
California Institute of Technology (Pasadena, CA) |
➤ Sign Up |
| Veliparib |
➤ Sign Up |
Substituted 4-(4-fluoro-3-(piperazine-1-carbonyl)benzyl)phthalazin-1(2H)-one derivatives as poly (ADP-ribose) polymerase-1 inhibitors |
Cadila Healthcare Limited (Ahmedabad, Gujarat, IN) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
